sb 239063 has been researched along with Anterior Circulation Transient Ischemic Attack in 2 studies
SB 239063: structure in first source
SB-239063 : A member of the class of imidazoles carrying 4-hydroxycyclohexyl, 4-fluorophenyl and 2-methoxypyrimidin-4-yl substituents at positions 1, 4 and 5 respectively.
Excerpt | Relevance | Reference |
---|---|---|
" dosing regimen that provided effective plasma concentrations of 0." | 1.31 | SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia. ( Adams, JL; Badger, AM; Barone, FC; Erhardt, JA; Hunter, AJ; Irving, EA; Kassis, S; Kumar, S; Lee, JC; Legos, JJ; McVey, MJ; Nelson, AH; Ohlstein, EH; Parsons, AA; Ray, AM; Smith, BR; Ward, K; White, RF, 2001) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barone, FC | 2 |
Irving, EA | 1 |
Ray, AM | 1 |
Lee, JC | 1 |
Kassis, S | 1 |
Kumar, S | 1 |
Badger, AM | 1 |
White, RF | 2 |
McVey, MJ | 1 |
Legos, JJ | 2 |
Erhardt, JA | 2 |
Nelson, AH | 1 |
Ohlstein, EH | 1 |
Hunter, AJ | 1 |
Ward, K | 1 |
Smith, BR | 1 |
Adams, JL | 1 |
Parsons, AA | 2 |
Lenhard, SC | 1 |
Chandra, S | 1 |
Tuma, RF | 1 |
2 other studies available for sb 239063 and Anterior Circulation Transient Ischemic Attack
Article | Year |
---|---|
SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Body Temperature; Brain; Cerebrovascular Circulati | 2001 |
SB 239063, a novel p38 inhibitor, attenuates early neuronal injury following ischemia.
Topics: Animals; Cell Death; Cerebral Infarction; Enzyme Inhibitors; Imidazoles; Ischemic Attack, Transient; | 2001 |